Table 4.
Systemic therapy
| Parameter | Arm A (n = 43), n (%) | Arm B (n = 45), n (%) |
|---|---|---|
| Systemic therapy | ||
| Chemotherapy | ||
| CAPOX | 42 (98) | 45 (100) |
| FOLFOX | 1 (2) | 0 |
| Bevacizumab | 25 (58) | 30 (67) |
| Completed equivalent of eight cycles CAP(OX) | 30 (70) | 29 (64) |
| Response at first evaluation | ||
| Complete remission | 0 (0) | 1 (2) |
| Partial remission | 21 (48) | 20 (44) |
| Stable disease | 22 (51) | 24 (53) |
| Progressive disease | n/a | n/a |
Abbreviations: CAPOX, capecitabine and oxaliplatin; FOLFOX, 5‐fluorouracil/leucovorin and oxaliplatin; n/a, not applicable.